Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data

BACKGROUND/OBJECTIVE: Patients with moderate‐to‐severe atopic dermatitis (AD) have increased risk of cutaneous and extracutaneous infections. Dupilumab has previously been associated with reduced risk of serious/severe infections and non‐herpetic skin infections in adults with moderate‐to‐severe AD....

Descripción completa

Detalles Bibliográficos
Autores principales: Paller, Amy S., Beck, Lisa A., Blauvelt, Andrew, Siegfried, Elaine C., Cork, Michael J., Wollenberg, Andreas, Chen, Zhen, Khokhar, Faisal A., Vakil, Jignesh, Zhang, Annie, Bansal, Ashish, Cyr, Sonya L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302614/
https://www.ncbi.nlm.nih.gov/pubmed/35083774
http://dx.doi.org/10.1111/pde.14909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302614/
https://www.ncbi.nlm.nih.gov/pubmed/35083774
http://dx.doi.org/10.1111/pde.14909

Ejemplares similares